Yuhan Corporation (000100.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 78,000.00

From 52W high−38.00%

Volume725468.00

Market capKRW 6.26T

P/E (TTM)27.1x

P/S (TTM)2.7x

Div yield0.77%

Key dataSep 18, 2026

Open

KRW 78,000.00

From 52W high

−38.00%

Volume

725468.00

Market cap

KRW 6.26T

ValuationView details →

P/E (Fwd)

51.8x

EV/EBITDA

28.5x

P/E (TTM)

27.1x

RSI (14)

39.2

MomentumView details →

1D Return

+0.26%

YTD Return

−32.47%

ValuationView details →

P/E (Fwd)

51.8x

P/E (TTM)

27.1x

EV/EBITDA

28.5x

EV/Sales

2.7x

P/S (TTM)

2.7x

P/B (TTM)

2.6x

ProfitabilityView details →

Gross Margin

34.30%

Net Margin

10.39%

EBITDA Margin

9.63%

ROE (TTM)

9.93%

ROA (TTM)

7.12%

Asset Turnover

0.69x

GrowthView details →

Revenue YoY

+5.40%

EPS YoY

+166.62%

FCF YoY

+120.39%

Revenue CAGR 3Y

+7.18%

EPS CAGR 3Y

+29.14%

EBITDA YoY

−21.32%

MomentumView details →

1D Return

+0.26%

YTD Return

−32.47%

1Y Return

−36.00%

RSI (14)

39.2

vs 50D SMA

−1.94%

vs 200D SMA

−18.10%

Capital & dividendView details →

Debt/Equity

0.15x

Current Ratio

2.27x

Quick Ratio

1.68x

Div Yield

0.77%

Div Rate

KRW 600.00

Div Growth 1Y

+20.00%

EarningsView details →

EPS (Actual)

KRW 868.64

EPS Surprise

27.50%

Beats (12Q)

1/12

Next Q EPS Est

KRW 328.20

Avg Surprise (4Q)

27.50%

Rev Surprise

2.67%

Financials snapshotView financials →

Revenue (TTM)

2.28T

Net Income (TTM)

237.09B

Op. CF (TTM)

165.66B

Next earningsNov 3, 2026 →

Latest newsMore news →

No recent news for 000100.KS.

Similar companies

Yuhan Corporation000105.KS Hanmi Pharm. Co., Ltd.128940.KS Hanall Biopharma Co.,Ltd009420.KS Celltrion Pharm, Inc.068760.KQ Daewoong pharmaceutical Co.,Ltd069620.KS JW Pharmaceutical Corporation001067.KS Find similar companies →

Latest newsMore news →

No recent news for 000100.KS.